Literature DB >> 12015921

The Role of Antigen-presenting Cells in HIV Pathogenesis.

Claire Chougnet1, Gene M. Shearer, Alan L. Landay.   

Abstract

The study of antigen-presenting cells (APC) in HIV pathogenesis has been ongoing for almost 20 years. The initial studies recognized the important role of APC as targets for HIV infection and their ability to serve as reservoirs of virus, particularly in tissues. The issue of whether HIV impacts the functional competency of APC has been more controversial, with some studies showing reduced expression of important costimulatory molecules on APC, but others showing the functional capacity of APC to be normal. The study of APC has advanced with recent interest in one class of APC, namely the dendritic cell. These cells have been shown to consist of numerous subsets and serve an important role in bridging innate and adaptive immune responses. The impact of HIV infection on dendritic cells has recently been characterized, as well as the critical functional role of these cells in host defenses in HIV-infected patients. One of the more exciting recent advances in APC biology is the ability to manipulate APC ex vivo for therapeutic purposes in an attempt to restore immune responses in HIV-infected persons. This review covers many of the advances of the field of APC biology and puts them into perspective with HIV pathogenesis.

Entities:  

Year:  2002        PMID: 12015921     DOI: 10.1007/s11908-002-0090-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  57 in total

1.  Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Authors:  L Al-Harthi; J Siegel; J Spritzler; J Pottage; M Agnoli; A Landay
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

2.  Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.

Authors:  C Chougnet; T A Wynn; M Clerici; A L Landay; H A Kessler; J Rusnak; G P Melcher; A Sher; G M Shearer
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

3.  Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.

Authors:  D Fuchs; M Gisslén; M Larsson; G Norkrans; L Hagberg; H Wachter
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

4.  CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients.

Authors:  C Chougnet; E Thomas; A L Landay; H A Kessler; S Buchbinder; S Scheer; G M Shearer
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

5.  Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12.

Authors:  A Blauvelt; C Chougnet; G M Shearer; S I Katz
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

6.  Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.

Authors:  L A Ryan; J Zheng; M Brester; D Bohac; F Hahn; J Anderson; W Ratanasuwan; H E Gendelman; S Swindells
Journal:  J Infect Dis       Date:  2001-08-15       Impact factor: 5.226

7.  Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.

Authors:  F Baribaud; S Pöhlmann; T Sparwasser; M T Kimata; Y K Choi; B S Haggarty; N Ahmad; T Macfarlan; T G Edwards; G J Leslie; J Arnason; T A Reinhart; J T Kimata; D R Littman; J A Hoxie; R W Doms
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

Authors:  M M Lederman; E Connick; A Landay; D R Kuritzkes; J Spritzler; M St Clair; B L Kotzin; L Fox; M H Chiozzi; J M Leonard; F Rousseau; M Wade; J D Roe; A Martinez; H Kessler
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

9.  Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity.

Authors:  A Dudhane; B Conti; T Orlikowsky; Z Q Wang; N Mangla; A Gupta; G P Wormser; M K Hoffmann
Journal:  AIDS Res Hum Retroviruses       Date:  1996-07-01       Impact factor: 2.205

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  3 in total

1.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.

Authors:  G d'Ettorre; G Forcina; M Andreotti; L Sarmati; L Palmisano; M Andreoni; S Vella; C M Mastroianni; V Vullo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

3.  Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.

Authors:  Nesrina Imami; Samantha J Westrop; Nathali Grageda; Anna A Herasimtschuk
Journal:  Front Immunol       Date:  2013-03-01       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.